Caltrate

Caltrate 600+D3 Plus Minerals

C
N+ Score70
Joint & BoneServing: 1 Tablet(s)Type: Other Combinations

Caltrate 600+D3 Plus Minerals is a bone health supplement providing 7 key ingredients. Each serving delivers Vitamin D3 (800 IU), Calcium (600mg), Zinc (7.5mg), Copper (1mg), and Manganese (1.8mg), all at clinically studied dosages known to support bone density and mineral absorption. However, the Magnesium content at 50mg is underdosed compared to research-backed levels for comprehensive bone support. This product holds an N+ Score of 70, giving it a 'C' grade, indicating a good quality product with several clinically dosed ingredients. It is well-suited for individuals focused on maintaining bone health and addressing potential deficiencies in these specific minerals and Vitamin D.

About This Product

Caltrate 600+D3 Plus Minerals by Caltrate is a joint & bone supplement containing 7 active ingredients. It has earned an N+ Score of 70/100 (Grade C).

Notable clinical-dose ingredients include Calcium, Zinc, Copper and 2 more.

N+ Score Breakdown

Ingredient Adequacy67/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness25/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity100/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms
  • +5 ingredient(s) at clinical dose levels

Weaknesses

  • −Missing several expected ingredients for its category

Ingredient Analysis (7 ingredients)

IngredientAmountDose Adequacy
Calcium600.000 mgOptimal
Magnesium50.000 mgUnder
Zinc7.500 mgAdequate
Copper1.000 mgOptimal
Manganese1.800 mgOptimal
Boron250.000 mcgN/A
Vitamin D3800.000 IUAdequate

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.